Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
07.04.26
/
50%
€112.90
Target price
07.04.27
€173.46
Performance (%)
17.98%
Price
19.08.26
€133.20
Summary
This prediction is currently active. The prediction currently has a performance of 17.98%. This prediction currently runs until 07.04.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.951% | -1.951% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Canaccord Genuity Group Inc. from $164.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€146.25
03.08.26
03.08.26
€182.15
03.08.27
03.08.27
-8.92%
19.08.26
19.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€89.90
30.03.23
30.03.23
€120.95
30.03.24
30.03.24
47.22%
01.04.24
01.04.24